Clinical trial
Drug Therapy for Alcohol Dependence in Alaska Natives (Naltrexone/Sertraline)
NCT00000451 · Yale University, Other · Completed
Key facts
| NCT number | NCT00000451 |
|---|---|
| Title | Drug Therapy for Alcohol Dependence in Alaska Natives (Naltrexone/Sertraline) |
| Official title | Naltrexone and SSRI Therapy for Alcohol Dependence in Alaska Natives |
| Lead sponsor | Yale University, Other |
| Collaborators | National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alcoholism, Alcohol Dependence |
| Intervention type | Drug |
| Interventions | sertraline, naltrexone |
| Enrollment | 198 |
| Start date | Jan 1, 2003 |
| Primary completion | Aug 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Nov 3, 1999 |
| Last update posted | Jan 29, 2013 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: